Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on July 20, 2026

Jul. 20, 2026

Kolon TissueGene Reports Topline ACTiVION-II Phase 3 Clinical Trial Results for TissueGene-C (TG-C) Targeting Osteoarthritis (OA) of the Knee

Indeterminate GlobeNewswire

Jul. 20, 2026

Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market

Indeterminate GlobeNewswire

Jul. 20, 2026

Canadian emergency rooms face critical challenges. This $15M gift will fuel innovation to help EDs address gaps in care.

Indeterminate GlobeNewswire

Jul. 20, 2026

BrainsWay Announces Strategic Investment in Radial Health, Inc.

Indeterminate GlobeNewswire

Jul. 20, 2026

Nouscom Selected for Oral Presentation on NOUS-209 Re-treatment and Long-Term Follow-Up in Lynch Syndrome Carriers at ESMO Congress 2026

Indeterminate GlobeNewswire

Jul. 20, 2026

VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

Indeterminate GlobeNewswire

Jul. 20, 2026

Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY

Indeterminate GlobeNewswire

Jul. 20, 2026

INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform

Indeterminate GlobeNewswire

Jul. 20, 2026

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

Indeterminate GlobeNewswire

Jul. 20, 2026

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies

Indeterminate GlobeNewswire

Jul. 20, 2026

Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology

Indeterminate GlobeNewswire

Jul. 20, 2026

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting

Indeterminate GlobeNewswire

Jul. 20, 2026

OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans

Indeterminate GlobeNewswire

Jul. 20, 2026

Vireo Growth Inc. to Acquire Certain Assets of The Cannabist Company Holdings Inc.

Indeterminate GlobeNewswire

Jul. 20, 2026

Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar

Indeterminate GlobeNewswire

Jul. 20, 2026

Frishantic Launches Chelated Magnesium Glycinate for Nighttime Calm and Daily Muscle Ease

Indeterminate GlobeNewswire

Jul. 20, 2026

Cytosurge elects veteran biotech executive, investor, and company builder Luba Greenwood, J.D., to its Board of Directors

Indeterminate GlobeNewswire